Trials / Recruiting
RecruitingNCT03830879
Shenzhen Birth Cohort Study
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 10,000 (estimated)
- Sponsor
- Sun Yat-sen University · Academic / Other
- Sex
- All
- Age
- 15 Years – 49 Years
- Healthy volunteers
- Accepted
Summary
The Shenzhen Birth Cohort Study was set up to investigate the effect of early life environmental exposures on short- and long-term health consequences in Shenzhen, China.
Detailed description
Shenzhen Birth Cohort (Xinmiao Project) is a scientific research/public health project under the support of Shenzhen city and Nanshan district, which was jointly initiated by Nanshan Maternity and Child Healthcare Hospital of Shenzhen and school of public health, Sun Yat-sen University. The project plans to recruit 10,000 participants in early pregnancy and follow up for seven years in the first stage. Biological samples, questionnaires and data for child growth and development, disease and health will be collected. The study is aimed to provide evidence for DOHaD Hypothesis and find the prevention and control measures for some childhood diseases. The core members of the research team are composed of experts from different disciplines in the field of public health, including 4 professors and 3 associate professors. With the support of an executive sponsor, the project is undertaken by the Birth Cohort Study Center. Currently, the center has 3 staff form hospital (one doctor and two masters ) and 5-7 master candidates from Sun Yat-sen University. It is an energetic and enthusiastic team.
Conditions
- Pregnancy Complications
- Gestational Diabetes
- Obstetric Labor Complications
- Neurodevelopmental Disorders
- Childhood Obesity
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No intervention | This cohort study have any no intervention. |
Timeline
- Start date
- 2018-03-06
- Primary completion
- 2025-03-05
- Completion
- 2032-12-31
- First posted
- 2019-02-05
- Last updated
- 2019-02-05
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03830879. Inclusion in this directory is not an endorsement.